The Delhi High Court on Thursday directed a Hyderabad-based pharmaceutical firm to seek a review by a competent authority of the price determined by National Pharmaceutical Pricing Authority for its tetanus vaccine. It also asked the company M/s Biological E Ltd, which manufactures a tetanus vaccine with the brand name Bett Tetanus Vaccineto, to deposit 25 per cent of the overcharged amount on its drug with it till the disposal of case.
“The appellants shall apply for a review of the price determined vide notification dated June 14, 2013, read with corrigendum dated February 17, 2014, in terms of Drug Price Control Order 2013, on or before January 30, 2015.
“If the review is filed within the time fixed above, the same shall be considered by the Government of India and an appropriate order shall be passed on or before March 4, 2015, following due process of law,” it said. The Bench headed by Chief Justice G. Rohini further directed the appellants to furnish security of 25 per cent of the amount demanded by NPPA with the Registrar General within two weeks.
